Rock Springs Capital Management LP 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 10:48 am Sale |
2025-03-31 | 13G | Xilio Therapeutics, Inc. XLO |
Rock Springs Capital Management LP | 0 0.000% |
-3,003,259 (Position Closed) |
Filing |
| 2024-11-12 4:50 pm Unchanged |
2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO |
Rock Springs Capital Management LP | 3,003,259 6.830% |
0 (Unchanged) |
Filing |
| 2024-04-05 2:51 pm Purchase |
2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO |
Rock Springs Capital Management LP | 3,003,259 8.710% |
3,003,259 (New Position) |
Filing |